from PRNewswire -- Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com